These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38104275)

  • 21. The development of nanocarriers for natural products.
    Huang L; Luo S; Tong S; Lv Z; Wu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid Nanoparticles and their Application in Nanomedicine.
    Rajabi M; Mousa SA
    Curr Pharm Biotechnol; 2016; 17(8):662-72. PubMed ID: 27087491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotechnology strategies to address challenges in topical and cellular delivery of siRNAs in skin disease therapy.
    Silvestrini AVP; Morais MF; Debiasi BW; Praça FG; Bentley MVLB
    Adv Drug Deliv Rev; 2024 Apr; 207():115198. PubMed ID: 38341146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular-targeted nanotherapies in cancer: enabling treatment specificity.
    Blanco E; Hsiao A; Ruiz-Esparza GU; Landry MG; Meric-Bernstam F; Ferrari M
    Mol Oncol; 2011 Dec; 5(6):492-503. PubMed ID: 22071376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Precise are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature.
    Mohapatra P; Gopikrishnan M; Doss C GP; Chandrasekaran N
    Int J Nanomedicine; 2024; 19():2441-2467. PubMed ID: 38482521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs.
    Ahmed T; Liu FF; Lu B; Lip H; Park E; Alradwan I; Liu JF; He C; Zetrini A; Zhang T; Ghavaminejad A; Rauth AM; Henderson JT; Wu XY
    Mol Pharm; 2022 Jun; 19(6):1722-1765. PubMed ID: 35587783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omics-based nanomedicine: the future of personalized oncology.
    Rosenblum D; Peer D
    Cancer Lett; 2014 Sep; 352(1):126-36. PubMed ID: 23941830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in nanotechnology-based platforms for survivin-targeted drug discovery.
    George R; Hehlgans S; Fleischmann M; Rödel C; Fokas E; Rödel F
    Expert Opin Drug Discov; 2022 Jul; 17(7):733-754. PubMed ID: 35593177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.
    Peng C; Huang Y; Zheng J
    J Control Release; 2020 Jun; 322():64-80. PubMed ID: 32194171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
    Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management.
    Huo D; Jiang X; Hu Y
    Adv Mater; 2020 Jul; 32(27):e1904337. PubMed ID: 31663198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming in vivo barriers to targeted nanodelivery.
    Chrastina A; Massey KA; Schnitzer JE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From nanotechnology to nanomedicine: applications to cancer research.
    Seigneuric R; Markey L; Nuyten DS; Dubernet C; Evelo CT; Finot E; Garrido C
    Curr Mol Med; 2010 Oct; 10(7):640-52. PubMed ID: 20712588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
    Mishra DK; Balekar N; Mishra PK
    Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.